Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

Abstract Background Low‐molecular‐weight‐heparins (LMWHs) have been established for the treatment of cancer‐associated venous thromboembolism (VTE). Recently published randomized controlled trials (RCTs) have compared direct oral anticoagulants (DOACs) with LMWHs. The aim of this systematic review a...

Full description

Bibliographic Details
Main Authors: Florian Moik, Florian Posch, Christoph Zielinski, Ingrid Pabinger, Cihan Ay
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
factor Xa inhibitors
low molecular weight heparin
neoplasms
venous thromboembolism
venous thrombosis
Online Access:https://doi.org/10.1002/rth2.12359

Similar Items

Similar Items